Clinical trial

Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH)…

NCT00493961 · Massachusetts General Hospital, Other · Completed

Key facts

NCT number NCT00493961
Title Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
Official title The Effects of 7 Days of Exogenous Pulsatile GnRH Treatment on the Pituitary-Gonadal Axis in Hypogonadotropic Hypogonadal Subjects
Lead sponsor Massachusetts General Hospital, Other
Status Completed
Phase Phase 1
Study type Interventional
Conditions Kallmann Syndrome, Idiopathic Hypogonadotropic Hypogonadism, GnRH Deficiency
Intervention type Drug
Interventions gonadotropin releasing hormone (GnRH)
Enrollment 27
Start date Jan 1, 1999
Primary completion Nov 17, 2009
Completion Nov 17, 2009
First posted Jun 29, 2007
Last update posted Jul 1, 2022
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies